Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Other long-term assets | (171) | — |
| Net cash used in operating activities | (17,577) | (147,659) |
| Cash flows from investing activities | ||
| Cash paid for property and equipment | (105) | (115) |
| Net cash used in investing activities | (105) | (115) |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock from exercise of stock options | 4,142 | 80 |
| Proceeds from issuance of long-term debt, net of issuance costs | 173,250 | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phathom Pharmaceuticals, Inc.'s capex?
- Phathom Pharmaceuticals, Inc. (PHAT) reported capex of $44K in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s capex changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s capex decreased by 54.6% year-over-year, from $97K to $44K.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s capex?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s capex has grown at a -8.6% compound annual growth rate (CAGR), from $328K to $229K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Phathom Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude